The endocytic adaptor protein Disabled-2 is required for cellular uptake of fibrinogen

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1778-1788

  Hung, Wei Shan ^a   Huang, Chien Ling ^a   Fan, Jui Ting ^a   Huang, Ding Yuan ^a   Yeh, Chun Fung ^a   Cheng, Ju Chien ^b   Tseng, Ching Ping ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Disabled 2; Endocytosis; Fibrinogen; Integrin IIb 3; Megakaryocytic differentiation

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN 2; ADAPTOR PROTEIN DAB2; ALPHA2 INTEGRIN; ALPHA2B BETA3 INTEGRIN; CHLORPROMAZINE; CLATHRIN; COLLAGEN; FIBRINOGEN; HYPERTONIC SOLUTION; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEGAKARYOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; WESTERN BLOTTING;

ADAPTOR PROTEIN COMPLEX 2; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CATTLE; CELL DIFFERENTIATION; CLATHRIN; ENDOCYTOSIS; FIBRINOGEN; HUMANS; K562 CELLS; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; STAINING AND LABELING; TETRADECANOYLPHORBOL ACETATE;

EID: 84864764954     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.06.008     Document Type: Article

References (72)

1. Lisman T., Weeterings C., de Groot P.G. Platelet aggregation: involvement of thrombin and fibrin(ogen). Front. Biosci. 2005, 10:2504-2517.
2. Mosesson M.W. Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 2005, 3:1894-1904.
3. Handagama P., Bainton D.F., Jacques Y., Conn M.T., Lazarus R.A., Shuman M.A. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules. J. Clin. Invest. 1993, 91:193-200.
4. Handagama P., Scarborough R.M., Shuman M.A., Bainton D.F. Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa). Blood 1993, 82:135-138.
5. Castaldi P.A., Larrieu M.J., Caen J. Availability of platelet factor 3 and activation of factor XII in thrombasthenia. Nature 1965, 207:422-424.
6. Coller B.S., Seligsohn U., West S.M., Scudder L.E., Norton K.J. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking. Blood 1991, 78:2603-2610.
7. Sorkin A. Cargo recognition during clathrin-mediated endocytosis: a team effort. Curr. Opin. Cell Biol. 2004, 16:392-399.
8. Mettlen M., Loerke D., Yarar D., Danuser G., Schmid S.L. Cargo- and adaptor-specific mechanisms regulate clathrin-mediated endocytosis. J. Cell Biol. 2010, 188:919-933.
9. Ohno H., Stewart J., Fournier M.C., Bosshart H., Rhee I., Miyatake S., Saito T., Gallusser A., Kirchhausen T., Bonifacino J.S. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 1995, 269:1872-1875.
10. Bonifacino J.S., Dell'Angelica E.C. Molecular bases for the recognition of tyrosine-based sorting signals. J. Cell Biol. 1999, 145:923-926.
11. Nordeng T.W., Bakke O. Overexpression of proteins containing tyrosine- or leucine-based sorting signals affects transferrin receptor trafficking. J. Biol. Chem. 1999, 274:21139-21148.
12. Hinrichsen L., Harborth J., Andrees L., Weber K., Ungewickell E.J. Effect of clathrin heavy chain- and alpha-adaptin-specific small inhibitory RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells. J. Biol. Chem. 2003, 278:45160-45170.
13. Motley A., Bright N.A., Seaman M.N., Robinson M.S. Clathrin-mediated endocytosis in AP-2-depleted cells. J. Cell Biol. 2003, 162:909-918.
14. Wolfe B.L., Trejo J. Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic 2007, 8:462-470.
15. Traub L.M. Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat. Rev. Mol. Cell Biol. 2009, 10:583-596.
16. Phillips D.R., Nannizzi-Alaimo L., Prasad K.S. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb. Haemost. 2001, 86:246-258.
17. Woodside D.G., Obergfell A., Leng L., Wilsbacher J.L., Miranti C.K., Brugge J.S., Shattil S.J., Ginsberg M.H. Activation of Syk protein tyrosine kinase through interaction with integrin beta cytoplasmic domains. Curr. Biol. 2001, 11:1799-1804.
18. Calderwood D.A., Fujioka Y., de Pereda J.M., Garcia-Alvarez B., Nakamoto T., Margolis B., McGlade C.J., Liddington R.C., Ginsberg M.H. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2272-2277.
19. Huang C.L., Cheng J.C., Liao C.H., Stern A., Hsieh J.T., Wang C.H., Hsu H.L., Tseng C.P. Disabled-2 is a negative regulator of integrin alpha(IIb)beta(3)-mediated fibrinogen adhesion and cell signaling. J. Biol. Chem. 2004, 279:42279-42289.
20. Zhao R., Pathak A.S., Stouffer G.A. beta(3)-Integrin cytoplasmic binding proteins. Arch. Immunol. Ther. Exp. 2004, 52:348-355.
21. Hughan S.C., Watson S.P. Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of Dok2 with integrin alphaIIbbeta3. J. Thromb. Haemost. 2007, 5:387-394.
22. Wegener K.L., Partridge A.W., Han J., Pickford A.R., Liddington R.C., Ginsberg M.H., Campbell I.D. Structural basis of integrin activation by talin. Cell 2007, 128:171-182.
23. Oxley C.L., Anthis N.J., Lowe E.D., Vakonakis I., Campbell I.D., Wegener K.L. An integrin phosphorylation switch: the effect of beta3 integrin tail phosphorylation on Dok1 and talin binding. J. Biol. Chem. 2008, 283:5420-5426.
24. Tseng C.P., Huang C.H., Tseng C.C., Lin M.H., Hsieh J.T., Tseng C.H. Induction of disabled-2 gene during megakaryocyte differentiation of K562 cells. Biochem. Biophys. Res. Commun. 2001, 285:129-135.
25. Tseng C.P., Huang C.L., Huang C.H., Cheng J.C., Stern A., Tseng C.H., Chiu D.T. Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. FEBS Lett. 2003, 541:21-27.
26. Tseng C.P., Chang P., Huang C.L., Cheng J.C., Chang S.S. Autocrine signaling of platelet-derived growth factor regulates disabled-2 expression during megakaryocytic differentiation of K562 cells. FEBS Lett. 2005, 579:4395-4401.
27. Huang C.L., Cheng J.C., Stern A., Hsieh J.T., Liao C.H., Tseng C.P. Disabled-2 is a novel alphaIIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation. J. Cell Sci. 2006, 119:4420-4430.
28. Drahos K.E., Welsh J.D., Finkielstein C.V., Capelluto D.G. Sulfatides partition disabled-2 in response to platelet activation. PLoS One 2009, 4:e8007.
29. Huang C.L., Cheng J.C., Kitajima K., Nakano T., Yeh C.F., Chong K.Y., Tseng C.P. Disabled-2 is required for mesoderm differentiation of murine embryonic stem cells. J. Cell. Physiol. 2010, 225:92-105.
30. Tseng C.P., Ely B.D., Li Y., Pong R.C., Hsieh J.T. Regulation of rat DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells. Endocrinology 1998, 139:3542-3553.
31. Tseng C.P., Ely B.D., Pong R.C., Wang Z., Zhou J., Hsieh J.T. The role of DOC-2/DAB2 protein phosphorylation in the inhibition of AP-1 activity. An underlying mechanism of its tumor-suppressive function in prostate cancer. J. Biol. Chem. 1999, 274:31981-31986.
32. Huang C.H., Cheng J.C., Chen J.C., Tseng C.P. Evaluation of the role of Disabled-2 in nerve growth factor-mediated neurite outgrowth and cellular signalling. Cell. Signal. 2007, 19:1339-1347.
33. Jain N., Nguyen H., Friedline R.H., Malhotra N., Brehm M., Koyanagi M., Bix M., Cooper J.A., Chambers C.A., Kang J. Cutting edge: Dab2 is a FOXP3 target gene required for regulatory T cell function. J. Immunol. 2009, 183:4192-4196.
34. Hannigan A., Smith P., Kalna G., Lo Nigro C., Orange C., O'Brien D.I., Shah R., Syed N., Spender L.C., Herrera B., Thurlow J.K., Lattanzio L., Monteverde M., Maurer M.E., Buffa F.M., Mann J., Chu D.C., West C.M., Patridge M., Oien K.A., Cooper J.A., Frame M.C., Harris A.L., Hiller L., Nicholson L.J., Gasco M., Crook T., Inman G.J. Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. J. Clin. Invest. 2010, 120:2842-2857.
35. Morris S.M., Arden S.D., Roberts R.C., Kendrick-Jones J., Cooper J.A., Luzio J.P., Buss F. Myosin VI binds to and localises with Dab2, potentially linking receptor-mediated endocytosis and the actin cytoskeleton. Traffic 2002, 3:331-341.
36. Spudich G., Chibalina M.V., Au J.S., Arden S.D., Buss F., Kendrick-Jones J. Myosin VI targeting to clathrin-coated structures and dimerization is mediated by binding to Disabled-2 and PtdIns(4,5)P2. Nat. Cell Biol. 2007, 9:176-183.
37. Maurer M.E., Cooper J.A. The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH. J. Cell Sci. 2006, 119:4235-4246.
38. Cuitino L., Matute R., Retamal C., Bu G., Inestrosa N.C., Marzolo M.P. ApoER2 is endocytosed by a clathrin-mediated process involving the adaptor protein Dab2 independent of its Rafts' association. Traffic 2005, 6:820-838.
39. Zhang H., Lee J.M., Wang Y., Dong L., Ko K.W., Pelletier L., Yao Z. Mutational analysis of the FXNPXY motif within LDL receptor-related protein 1 (LRP1) reveals the functional importance of the tyrosine residues in cell growth regulation and signal transduction. Biochem. J. 2008, 409:53-64.
40. Maurer M.E., Cooper J.A. Endocytosis of megalin by visceral endoderm cells requires the Dab2 adaptor protein. J. Cell Sci. 2005, 118:5345-5355.
41. Pedersen G.A., Chakraborty S., Steinhauser A.L., Traub L.M., Madsen M. AMN directs endocytosis of the intrinsic factor-vitamin B(12) receptor cubam by engaging ARH or Dab2. Traffic 2010, 11:706-720.
42. Chao W.T., Kunz J. Focal adhesion disassembly requires clathrin-dependent endocytosis of integrins. FEBS Lett. 2009, 583:1337-1343.
43. Teckchandani A., Toida N., Goodchild J., Henderson C., Watts J., Wollscheid B., Cooper J.A. Quantitative proteomics identifies a Dab2/integrin module regulating cell migration. J. Cell Biol. 2009, 186:99-111.
44. Chao W.T., Ashcroft F., Daquinag A.C., Vadakkan T., Wei Z., Zhang P., Dickinson M.E., Kunz J. Type I phosphatidylinositol phosphate kinase beta regulates focal adhesion disassembly by promoting beta1 integrin endocytosis. Mol. Cell. Biol. 2010, 30:4463-4479.
45. Penheiter S.G., Deep Singh R., Repellin C.E., Wilkes M.C., Edens M., Howe P.H., Pagano R.E., Leof E.B. Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2. Mol. Biol. Cell 2010, 21:4009-4019.
46. Gray D.C., Hoeflich K.P., Peng L., Gu Z., Gogineni A., Murray L.J., Eby M., Kljavin N., Seshagiri S., Cole M.J., Davis D.P. pHUSH: a single vector system for conditional gene expression. BMC Biotechnol. 2007, 7:61.
47. Levine R.F., Fedorko M.E. Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique. J. Cell Biol. 1976, 69:159-172.
48. Bouchard B.A., Williams J.L., Meisler N.T., Long M.W., Tracy P.B. Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event. J. Thromb. Haemost. 2005, 3:541-551.
49. Salsmann A., Schaffner-Reckinger E., Kabile F., Plancon S., Kieffer N. A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin alphaIIbbeta3-dependent RhoA activation during cell spreading. J. Biol. Chem. 2005, 280:33610-33619.
50. Basani R.B., D'Andrea G., Mitra N., Vilaire G., Richberg M., Kowalska M.A., Bennett J.S., Poncz M. RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb). J. Biol. Chem. 2001, 276:13975-13981.
51. Mohri H., Ohkubo T. The role of the RGD peptides and the gamma chain peptide of fibrinogen on fibrinogen binding to activated platelets. Peptides 1993, 14:353-357.
52. Zucker M.B., Masiello N.C. Platelet aggregation caused by dithiothreitol. Thromb. Haemost. 1984, 51:119-124.
53. Kashiwagi H., Shiraga M., Honda S., Kosugi S., Kamae T., Kato H., Kurata Y., Tomiyama Y. Activation of integrin alpha IIb beta 3 in the glycoprotein Ib-high population of a megakaryocytic cell line, CMK, by inside-out signaling. J. Thromb. Haemost. 2004, 2:177-186.
54. Ylanne J., Huuskonen J., O'Toole T.E., Ginsberg M.H., Virtanen I., Gahmberg C.G. Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis. J. Biol. Chem. 1995, 270:9550-9557.
55. Gawaz M., Besta F., Ylanne J., Knorr T., Dierks H., Bohm T., Kolanus W. The NITY motif of the beta-chain cytoplasmic domain is involved in stimulated internalization of the beta3 integrin A isoform. J. Cell Sci. 2001, 114:1101-1113.
56. Ezratty E.J., Bertaux C., Marcantonio E.E., Gundersen G.G. Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells. J. Cell Biol. 2009, 187:733-747.
57. Conner S.D., Schmid S.L. Differential requirements for AP-2 in clathrin-mediated endocytosis. J. Cell Biol. 2003, 162:773-779.
58. Hill S.A., Shaughnessy S.G., Joshua P., Ribau J., Austin R.C., Podor T.J. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line. Blood 1996, 87:5061-5073.
59. El Golli N., Issertial O., Rosa J.P., Briquet-Laugier V. Evidence for a granule targeting sequence within platelet factor 4. J. Biol. Chem. 2005, 280:30329-30335.
60. Sehgal S., Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J. Thromb. Haemost. 2007, 5:2009-2016.
61. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009, 23:177-189.
62. Bouchard B.A., Meisler N.T., Nesheim M.E., Liu C.X., Strickland D.K., Tracy P.B. A unique function for LRP-1: a component of a two-receptor system mediating specific endocytosis of plasma-derived factor V by megakaryocytes. J. Thromb. Haemost. 2008, 6:638-644.
63. Ehrlich M., Boll W., Van Oijen A., Hariharan R., Chandran K., Nibert M.L., Kirchhausen T. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 2004, 118:591-605.
64. Boucrot E., Saffarian S., Zhang R., Kirchhausen T. Roles of AP-2 in clathrin-mediated endocytosis. PLoS One 2010, 5:e10597.
65. Mayor S., Pagano R.E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 2007, 8:603-612.
66. Glebov O.O., Bright N.A., Nichols B.J. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell Biol. 2006, 8:46-54.
67. Kirkham M., Parton R.G. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim. Biophys. Acta 2005, 1745:273-286.
68. Ballarin L., Burighel P. RGD-containing molecules induce macropinocytosis in ascidian hyaline amoebocytes. J. Invertebr. Pathol. 2006, 91:124-130.
69. Handagama P.J., Amrani D.L., Shuman M.A. Endocytosis of fibrinogen into hamster megakaryocyte alpha granules is dependent on a dimeric gamma A configuration. Blood 1995, 85:1790-1795.
70. Shiraga M., Ritchie A., Aidoudi S., Baron V., Wilcox D., White G., Ybarrondo B., Murphy G., Leavitt A., Shattil S. Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signaling. J. Cell Biol. 1999, 147:1419-1430.
71. Schober J.M., Lam S.C., Wencel-Drake J.D. Effect of cellular and receptor activation on the extent of integrin alphaIIbbeta3 internalization. J. Thromb. Haemost. 2003, 1:2404-2410.
72. Welsh J.D., Charonko J.J., Salmanzadeh A., Drahos K.E., Shafiee H., Stremler M.A., Davalos R.V., Capelluto D.G., Vlachos P.P., Finkielstein C.V. Disabled-2 modulates homotypic and heterotypic platelet interactions by binding to sulfatides. Br. J. Haematol. 2011, 154:122-133.